HIGHLIGHTS
- who: Parnrada Nulsopapon et al. from the Isolated from Multi-Centers in Western Thailand Department of, Faculty of, Silpakorn University, Nakhon Pathom, Thailand have published the paper: Antimicrobial Activity Profiles and Potential Antimicrobial Regimens against Carbapenem-Resistant Enterobacterales Isolated from Multi-Centers in Western Thailand, in the Journal: Antibiotics
- what: Carbapenem-containing regimens are inappropriate for CRE treatment in the setting because none of the CRE isolates in the study had Ambler class A (KPC), and most CRE isolates provided meropenem MICs >8 µg/mL Colistin may be one option given its activities against CRE . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.